COMMUNIQUÉS West-GlobeNewswire

Smith+Nephew to showcase leading shoulder technologies for joint repair and reconstruction at ICSES 2026
21/09/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder [...]
European Commission approval of ICOTYDE™▼(icotrokinra) ushers in new era for first-line systemic treatment of plaque psoriasis with a targeted oral peptide
21/09/2026
Johnson & Johnson introduces the first IL-23R targeted oral peptide that can deliver skin clearance and a favourable safety profile in a once-daily pill. 1,2 ICOTYDE™ (icotrokinra) offers an innovative new option [...]
Transactions under Novonesis’ share buyback program
21/09/2026
Please read the announcement in PDF Attachment 2026_18_Share_buyback
Siemens Healthineers and Novo Join Forces to Advance Care for People Living with MASLD and MASH
21/09/2026
Tarrytown, New York, USA, Sept. 21, 2026 (GLOBE NEWSWIRE) -- People most at risk for MASLD/MASH remain largely unaware of the disease and its wider health risks Patients facing this metabolic condition benefit from [...]
Leads Biolabs’ Pivotal Phase IIb Study of Opamtistomig (LBL-024) in Advanced EP-NEC Selected as ESMO 2026 Late-Breaking Abstract; Three Studies Selected for Proffered Paper Presentations
21/09/2026
NANJING, China, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its pivotal registrational Phase IIb study of opamtistomig [...]
Zealand Pharma - Transactions related to share buy-back program (week 38, 2026)
21/09/2026
Company announcement No. 49 / 2026 Zealand Pharma - Transactions related to share buy-back program (week 38, 2026) Copenhagen, Denmark, September 21, 2026 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq [...]
European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)
21/09/2026
By continuously delivering medicine into the eye through the Contivue refillable implant, Susvimo is the first and only continuous delivery treatment that offers an alternative to standard-of-care eye injections for [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 août 2026
21/09/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Comprehensive Healthcare funds additional faculty position to grow Central Washington University’s graduate counseling program
21/09/2026
Ongoing collaboration addresses growing need for behavioral health professionals regionally YAKIMA, Wash., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare is proud to announce more than $300,000 in funding [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
21/09/2026
Déclaration de transactions sur actions propres Paris, France (21 septembre 2026, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 28 avril 2026, EssilorLuxottica déclare que le 18 septembre [...]
EssilorLuxottica: Disclosure of transactions in own shares
21/09/2026
Disclosure of transactions in own shares Paris, France (September 21, 2026 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 28, 2026, EssilorLuxottica declares that [...]
Cullinan Therapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
21/09/2026
CAMBRIDGE, Mass., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a clinical-stage biopharmaceutical company accelerating potential first- or best-in-class, disease-modifying T [...]
Signature d’une nouvelle ligne de crédit renouvelable syndiquée de 700 millions d’euros à échéance 2031
21/09/2026
Communiqué de presse 21 septembre 2026 Signature d’une nouvelle ligne de crédit renouvelable de 700 millions d’euros à échéance 2031 Paris, le 21 septembre 2026 : à la suite du succès de son offre de 500 millions d’ [...]
Signing of a new €700 million syndicated revolving credit facility maturing 2031
21/09/2026
Press Release 21 September 2026 Signing of a new €700 million revolving credit facility maturing in 2031 Paris, 21 September 2026 : following the success of its €500 million senior bonds offering completed on 8 [...]
Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial
21/09/2026
CagriSema 1.0 mg/1.0 mg achieved superior weight loss of 12.4%* versus tirzepatide 5 mg of 9.1%* and non-inferior HbA 1c reduction at week 60 in adults with type 2 diabetes in REIMAGINE 5. CagriSema 1.0 mg/1.0 mg [...]
Underarm Pad Surface Area and Handle Angle: The Measurements Behind Crutch Comfort
21/09/2026
Drive Medical builds the MD by Drive Air-Crutch handle angle and grip size around load calculations run at the handgrip by Max Younger, who designed the crutch and now leads the line. The Airgonomic™ underarm cushion [...]
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
21/09/2026
BOSTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
21/09/2026
The Shared Goals: Navigating Alzheimer’s Agitation survey finds that Alzheimer’s disease agitation is often only recognized after daily life is significantly disrupted Ninety-seven percent of care partners reported that [...]
Seer Announces CFO Transition
21/09/2026
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the [...]

Pages